Radiopharmaceutical may benefit patients with metastatic prostate cancer sooner
Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a Phase III clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, ...
16 hours ago
0
5









